The Lancet Respiratory Medicine in conversation with
Een podcast door The Lancet Group
156 Afleveringen
-
Inhaled budesonide in the treatment of early COVID-19
Gepubliceerd: 15-4-2021 -
Tocilizumab and COVID-19
Gepubliceerd: 5-3-2021 -
Interferon treatment and COVID-19
Gepubliceerd: 6-2-2021 -
Evaluating deterioration in patients with acute COVID-19
Gepubliceerd: 12-1-2021 -
Treatment options in patients with systemic sclerosis-associated interstitial lung disease
Gepubliceerd: 5-1-2021 -
COVID-19 and severe influenza
Gepubliceerd: 18-12-2020 -
The second wave and homeless populations
Gepubliceerd: 11-11-2020 -
Corticosteroids, COPD, asthma and COVID-19
Gepubliceerd: 25-9-2020 -
Novel strategies to drive down the global burden of asthma
Gepubliceerd: 8-9-2020 -
The pathology of suspected EVALI
Gepubliceerd: 5-8-2020 -
Wheezing illness and RSV-LRTI
Gepubliceerd: 17-7-2020 -
Antibiotic use in infancy and asthma incidence
Gepubliceerd: 16-3-2020 -
Guidance on the development of prediction models for critical care
Gepubliceerd: 12-3-2020 -
Potential exacerbations in patients with COPD
Gepubliceerd: 3-3-2020 -
CPAP and mild obstructive sleep apnea
Gepubliceerd: 28-11-2019 -
An algorithm for EVALI
Gepubliceerd: 8-11-2019 -
Lung transplants from Hepatitis C viremic donors
Gepubliceerd: 5-10-2019 -
Looking to the future of cystic fibrosis care
Gepubliceerd: 29-9-2019 -
Pamrevlumab and idiopathic pulmonary fibrosis
Gepubliceerd: 27-9-2019 -
Nicotine patches, e-cigarettes, and smoking cessation
Gepubliceerd: 10-9-2019
Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.
